Patents
Patents for C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media (9,992)
04/2003
04/11/2003WO2004096982A2 Antibacterial agents
04/10/2003WO2003029436A2 Ul16 binding protein 4
04/10/2003WO2003029425A2 Whole cell engineering using real-time metabolic flux analysis
04/10/2003US20030068678 WISP polypeptides and nucleic acids encoding same
04/10/2003CA2462790A1 Ul16 binding protein 4
04/09/2003EP1298991A2 High purity x-chromosome bearing and y-chromosome bearing populations of spermatozoa
04/03/2003WO2003027264A2 Coisogenic eukaryotic cell collections
04/03/2003WO2003027263A2 Proteins associated with cell growth, differentiation, and death
04/03/2003WO2003027262A2 Biological discovery using gene regulatory networks generated from multiple-disruption expression libraries
04/03/2003WO2003027254A2 15625 receptor, a novel g-protein coupled receptor
04/03/2003WO2003027228A2 Receptors and membrane-associated proteins
04/03/2003WO2003026584A2 Stem cells of the islets of langerhans and their use in treating diabetes mellitus
04/03/2003WO2002024909A9 Receptor nucleic acids and polypeptides
04/03/2003CA2461864A1 Biological discovery using gene regulatory networks generated from multiple-disruption expression libraries
04/03/2003CA2461861A1 Stem cells of the islets of langerhans and their use in treating diabetes mellitus
04/03/2003CA2460953A1 Proteins associated with cell growth, differentiation, and death
04/03/2003CA2453985A1 Receptors and membrane-associated proteins
04/02/2003EP1297108A2 Cell lines and cell-based assays for identification of androgen receptor modulators
04/02/2003CN1104502C Genes encoding branched-chain alpha-Ketoacid dehydrogenase complex from streptomyces avermitilis
04/01/2003US6541620 Antagonist for tumor necrosis factor; antiinflammatory agents; rheumatic diseases
03/2003
03/27/2003WO2003002715A3 Compositions and methods for labeling oligonucleotides
03/26/2003CN1406283A Method of purifying a fermentation broth
03/25/2003US6537776 Synthetic ligation reassembly in directed evolution
03/20/2003WO2003023014A2 Human ion channels
03/20/2003WO2003023010A2 Sensory neuron receptors
03/20/2003WO2003023008A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
03/20/2003WO2003022215A2 Compositions and methods for priming monocytic dendritic cells and t cells for th-1 response
03/20/2003WO2002077194A3 Polymer synthesis
03/20/2003US20030055000 Non-natural galanin receptor ligands
03/20/2003CA2459713A1 Compositions and methods for priming monocytic dendritic cells and t cells for th-1 response
03/20/2003CA2451454A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
03/19/2003EP1292667A2 Identification and use of molecular markers indicating cellular reprogramming
03/19/2003CN1404526A Method of making embryoid bodies from primate embryonic stem cells
03/18/2003US6534638 Recombinant DNA molecules encoding aminopeptidase enzymes and their use in the preparation of vaccines against helminth infections
03/13/2003WO2003020892A2 Bv8 NUCLEIC ACIDS AND POLYPEPTIDES WITH MITOGENIC ACTIVITY
03/13/2003WO2002030986A3 HUMANIZED ANTI-LT-β-R ANTIBODIES
03/13/2003US20030049811 Generation of granulate for use in animal feeds; prepare enzyme, water and solid support, recover granules and dry
03/13/2003US20030049725 Anti-TNF antibodies, compositions, methods and uses
03/13/2003CA2458670A1 Bv8 nucleic acids and polypeptides with mitogenic activity
03/12/2003EP1290178A2 Corynebacterium glutamicum genes encoding stress, resistance and tolerance proteins
03/12/2003EP1290136A1 Novel probiotics for pet food applications
03/11/2003US6531649 Transgenic sugar beet plant expressing cp4/epsps enzyme activity
03/11/2003US6531312 Isolated nucleic acid of given sequence
03/06/2003WO2002051994A8 Polypeptides
03/06/2003US20030045704 Chromosome 17p-linked prostrate cancer susceptibility gene and a paralog and orthologous genes
03/06/2003US20030044959 Chromosome 17p-linked prostrate cancer susceptibility gene and a paralog and orthologous genes
02/2003
02/27/2003WO2001098457A3 Surface model of a protein
02/27/2003WO2001075164A3 Rna sequence-specific mediators of rna interference
02/27/2003US20030039646 Receptor interacting protein, which binds to itself and to other intracellular modulatory proteins; treating tumor cells or HIV-infected cells
02/26/2003EP0665882B1 Dna compounds comprising sequences encoding mannuronan c-5-epimerase
02/20/2003WO2003014308A2 Cysteine mutants and methods for detecting ligand binding to biological molecules
02/20/2003WO2003014294A2 Tacis and br3 polypeptides and uses thereof
02/20/2003WO2002096262A3 Non-alloying core shell nanoparticles
02/20/2003US20030036857 Methods and systems of biomolecular sequence matching
02/20/2003CA2454246A1 Cysteine mutants and methods for detecting ligand binding to biological molecules
02/20/2003CA2453995A1 Tacis and br3 polypeptides and uses thereof
02/13/2003US20030032609 Promoting agniogenesis with a compound that increases expression of VEGF; inhibiting angiogenesis with a compound that inhibits binding of endothelial PAS domain protein-1 to cis-acting transcription regulatory DNA an angiogenic factor.
02/13/2003US20030032059 Gene recombination and hybrid protein development
02/13/2003US20030032030 Determination of age in animals; obtain tissue sample from animal, monitor expression pattern of marker gene, compare to expression pattern in younger control, evaluate sample for aging
02/13/2003US20030031657 Stem cells and their use in transplantation
02/11/2003US6518485 Particle-mediated conifer transformation
02/06/2003US20030026800 Monoclonal antibodies, antigens and diagnosis and therapy of malignant diseases
02/05/2003EP1281714A1 Magnetic pigment
02/05/2003EP1281154A2 Identifying clusters of transcription factor binding sites
02/05/2003EP1280912A2 Isolation and characterization of the csa operon (etec-cs4 pili) and methods of using same
01/2003
01/30/2003WO2003008565A1 Recovery of bioleaching microbes
01/30/2003WO2003008539A2 Non-alloying core shell nanoparticles
01/30/2003WO2003008533A2 Method for virus propagation
01/30/2003CA2452777A1 Recovery of bioleaching microbes
01/28/2003US6511841 Streptomyces avermitilis gene directing the ratio of B2:B1 avermectins
01/23/2003WO2003006690A1 Use of urokinase gene amplification as a marker
01/23/2003WO2003006625A2 Nucleotide compositions comprising photocleavable markers and methods of preparation thereof
01/23/2003WO2003006612A2 Production of transduced hematopoietic progenitor cells
01/23/2003US20030017160 Human checkpoint kinase, hCDS1, compositions and methods
01/23/2003US20030017142 Used to culture cells with transport of oxygen through the membrane (i.e., direct oxygenation), without regard for the flow rate of the liquid medium passing through the device; liver assist systems
01/23/2003CA2453187A1 Production of transduced hematopoietic progenitor cells
01/22/2003CN1392248A Broad spectrum bacillus thuringiensis and the method for preparing pesticide therewith
01/21/2003US6509159 Methods related to Streptomyces avermitilis gene directing the ratio of B2:B1 avermectins
01/16/2003WO2001081542A9 Feature extraction and normalization algorithms for high-density oligonucleotide gene expression array data
01/16/2003CA2785699A1 Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof
01/09/2003WO2003002715A2 Compositions and methods for labeling oligonucleotides
01/09/2003WO2003001876A2 T1r hetero-oligomeric taste receptors and cell lines that express said receptors and use thereof for identification of taste compounds
01/09/2003WO2001092463A3 Method of rna cleavage
01/09/2003CA2451317A1 T1r hetero-oligomeric taste receptors and cell lines that express said receptors and use thereof for identification of taste compounds
01/07/2003US6503717 Detecting gene asociated with preferential phenotype; obtain preferential nucleotide sequences, transduce cells, culture cells, recover cell of preferential phenotype, monitor gene expression in recovered cells
01/03/2003WO2003000849A2 Methods for representing sequence-dependent contextual information present in polymer sequences and uses thereof
01/03/2003WO2003000842A2 Novel proteins and nucleic acids encoding same
01/02/2003EP1268509A1 Mammalian sphingosine kinase type 2 isoforms, cloning, expression and methods of use thereof
12/2002
12/31/2002US6500438 In ovo vaccination against coccidiosis
12/31/2002US6500426 Carbohydrate-based enzyme-containing granules for use in animal feed
12/27/2002WO2002103040A1 Viral drug susceptibility testing
12/27/2002WO2002103008A2 Templated molecules and methods for using such molecules
12/27/2002WO2002051994A3 Polypeptides
12/27/2002CA2451524A1 Templated molecules and methods for using such molecules
12/26/2002US20020197692 Methods of isolating amyloid-inhibiting compounds and use of compounds isolated from Uncaria tomentosa and related plants
12/26/2002US20020197675 Glial nerovus system modulator for use in the treatment of nervous system disorders and spine damage
12/25/2002CN1387570A Fibroblast growth factor-19 (FGF-19) nucleic acids and polypeptides and methods of use for treatment of obesity
12/19/2002WO2002101069A2 Ns4 nucleic acids and polypeptides and methods of use for the treatment of body weight disorders
12/19/2002US20020192818 Recovering cryopreserved conifer embryogenic cultures
12/19/2002CA2449602A1 Ns4 nucleic acids and polypeptides and methods of use for the treatment of body weight disorders
1 ... 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 ... 100